Urogen Pharma Ltd (URGN)

EBITDA

-$3.17M

Quarterly · Period ending: · USD

URGN logo

URGN EBITDA

Latest reported-$3.17M
URGN Quarterly EBITDA (-$1.19M → -$3.17M)
High-resolution chart · PNG

URGN ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-3,167,000
-19,003,000
-22,188,000
-25,768,000
-48,818,000
-38,886,000
-26,252,000
-14,680,000
-29,641,000
-23,774,000
-7,423,000
-12,179,000
-19,890,000
-26,204,000
-24,507,000
-21,993,000
-18,111,000
-27,329,000
-19,444,000
-29,759,000
-25,468,000
-25,686,000
-26,639,000
-28,626,000
-31,325,000
-37,294,000
-38,703,000
-23,388,000
-23,693,000
-22,370,000
-23,940,000
-21,031,000
-18,383,000
-13,400,000
-10,100,000
-286,000
-5,864,000
-3,493,000
13,982,000
-6,053,000
-3,357,000
-3,561,000
-6,928,000
-2,016,000
-1,187,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.